QQ客服 官方微博 反馈留言

浏览/检索结果: 共11条，第1-10条 帮助 限定条件 发表日期：2015     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A phase III study of fulvestrant 500 mg versus 250 mg in postmenopausal Chinese women with advanced breast cancer and disease progression following failure on prior antiestrogen or aromatase inhibitor therapy: Supporting superior clinical benefit for the 会议论文 作者:  Jiang, Zefei;  Zhang, Qingyuan;  Shao, Zhimin;  Shen, Kunwei;  Li, Li 收藏  |  浏览/下载：59/0  |  提交时间：2019/12/13 National consensus in China on diagnosis and treatment of patients with advanced breast cancer 期刊论文 TRANSLATIONAL CANCER RESEARCH, 2015, 卷号: 4, 期号: 5 作者:  Xu, Binghe;  Hu, Xichun;  Jiang, Zefei;  Li, Huiping;  Chen, Jiayi 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/13 Advanced breast cancer (ABC)  consensus  national  China   Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+advanced breast cancer: BOLERO-1 会议论文 作者:  Hurvitz, Sara A.;  Andre, Fabrice;  Jiang, Zefei;  Shao, Zhimin;  Neciosup, Silvia P. 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/19 Gemcitabine with cisplatin or paclitaxel in metastatic triple-negative breast cancer 会议论文 作者:  Hu, Xichun;  Xu, Binghe;  Cai, Li;  Wang, Zhonghua;  Wang, Biyun 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19 Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial 期刊论文 LANCET ONCOLOGY, 2015, 卷号: 16, 期号: 7 作者:  Hurvitz, Sara A.;  Andre, Fabrice;  Jiang, Zefei;  Shao, Zhimin;  Mano, Max S. 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19 National consensus in China on diagnosis and treatment of patients with advanced breast cancer 期刊论文 ANNALS OF TRANSLATIONAL MEDICINE, 2015, 卷号: 3, 期号: 17 作者:  Xu, Binghe;  Hu, Xichun;  Jiang, Zefei;  Li, Huiping;  Chen, Jiayi 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/19 Advanced breast cancer (ABC)  consensus  national  China   A phase III study of fulvestrant 500 mg versus 250 mg in postmenopausal Chinese women with advanced breast cancer and disease progression following failure on prior antiestrogen or aromatase inhibitor therapy: Supporting superior clinical benefit 期刊论文 2015, 卷号: 75 作者:  Jiang, Zefei;  Zhang, Qingyuan;  Shao, Zhimin;  Shen, Kunwei;  Li, Li 收藏  |  浏览/下载：59/0  |  提交时间：2020/01/04 A phase III study of fulvestrant 500 mg versus 250 mg in postmenopausal Chinese women with advanced breast cancer and disease progression following failure on prior antiestrogen or aromatase inhibitor therapy: Supporting superior clinical benefit 会议论文 CANCER RESEARCH, 2015-05-01 作者:  Jiang, Zefei;  Zhang, Qingyuan;  Shao, Zhimin;  Shen, Kunwei;  Li, Li 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/04 Gemcitabine with cisplatin or paclitaxel in metastatic triple-negative breast cancer 会议论文 CANCER RESEARCH, 2015-05-01 作者:  Hu, Xichun;  Xu, Binghe;  Cai, Li;  Wang, Zhonghua;  Wang, Biyun 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 National consensus in China on diagnosis and treatment of patients with advanced breast cancer 期刊论文 2015, 卷号: 4, 期号: 5, 页码: 557-573 作者:  Xu, Binghe;  Hu, Xichun;  Jiang, Zefei;  Li, Huiping;  Chen, Jiayi 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04 Advanced breast cancer (ABC)  consensus  national  China